Given the known roles of these genes in hepatic lipid metabolism (36–38), it is highly likely that reduced Tcf7l2 expression promotes an increase in cholesterol synthesis, trafficking and secretion from hepatoma cells. Here, TCF7L2 is linked to hepatocellular carcinoma.